Eicosanoid secretion by human endothelial cells exposed to normal pregnancy and preeclampsia plasma in vitro

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 58, Issue 2, 1998, Pages 91-97

  De Groot, C J M ^a   Murai, J T ^b   Vigne, J L ^b   Taylor, R N ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; 8 ISOPROSTANE; ICOSANOID; PROSTACYCLIN; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ICOSANOID METABOLISM; MATERNAL PLASMA; PREECLAMPSIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; THIN LAYER CHROMATOGRAPHY; UMBILICAL CORD; VASCULAR ENDOTHELIUM;

EID: 0031913024     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(98)90146-6     Document Type: Article

References (36)

1. Roberts J. M., Taylor R. N., Musci T. J., Rodgers G. M., Hubel C. A., McLaughlin M. K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-1204.
2. Friedman S. A., Taylor R. N., Roberts J. M. Pathophysiology of preeclampsia. Clin Perinatol 1991; 18: 661-682.
3. Spector A. A. Lipid and lipoprotein effects on endothelial eicosanoid formation. Semin Thromb Hemost 1988; 14: 196-201.
4. Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663-665.
5. Friedman S. A. Preeclampsia: A review of the role of prostaglandins. Obstet Gynecol 1988; 71: 122-137.
6. de Groot C. J. M., Davidge S. T., Friedman S. A., McLaughlin M. K., Roberts J. M., Taylor R. N. Plasma from preeclamptic women increases human endothelial cell prostacyclin production without changes in enzyme activity or mass. AmJ Obstet Gynecol 1995; 172: 976-985.
7. Branch D. W., Dudley D. J., LaMarche S., Mitchell M. D. Sera from preeclamptic patients contain factor(s) that stimulate prostacyclin production by human endothelial cells. Prostaglandins Leukot Essent Fatty Acids 1992; 45: 191-195.
8. Chesley L. C. Diagnosis of preeclampsia. Obstet Gynecol 1985; 65: 423-425.
9. Lind T., Godfrey K. A., Otun H. Changes in serum uric acid concentrations during normal pregnancy. BrJ Obstet Gynaecol 1984; 91: 128-132.
10. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756.
11. Jaffe E. A., Hoyer L. W., Nachman R. L. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973; 52: 2757-2764.
12. Taylor R. N., Musci T. J., Kuhn R. W., Roberts J. M. Partial characterization of a novel growth factor from the blood of women with preeclampsia. J Clin Endocrinol Metab 1990; 70: 1285-1291.
13. Eling T., Tainer B., Ally A., Warnock R. Separation of arachidonic acid metabolites by high-pressure liquid chromatography. In: Methods in Enzymology. Academic Press, Inc., 1982: 511-517. vol 86.
14. Salmon J. A., Flower R. J. Extraction and thin-layer chromatography of arachidonic acid metabolites. In: Methods in Enzymology. Academic Press, Inc., 1982: 477-493. vol 86.
15. Roberts L. J. II; Morrow J. D. Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury. Ann NY Acad Sci 1994; 744: 237-242.
16. Sibai B. M., Caritis S. N., Thom E. et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993; 329: 1213-1218.
17. Hauth J., Goldenberg R., Parker C., Jr. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol 1993; 168: 1083-1093.
18. CLASP. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619-629.
19. Marcus A. J., Weksler B. B., Jaffe E. A. Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells. J Biol Chem 1978; 253: 7138-7141.
20. Lockwood C. J., Peters J. H. Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 1990; 162: 358-362.
21. Taylor R. N., Varma M., Teng N. N. H., Roberts J. M. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990; 71: 1675-1677.
22. Hsu C. D., Iriye B., Johson T. R. B., Witter F. R, Hong S. F., Chan D. W. Elevated circulating thrombomodulin in severe preeclampsia. Am J Obstet Gynecol 1993; 169: 148-149.
23. Demers L. M., Gabbe S. G. Placental prostaglandin levels in preeclampsia. Am J Obstet Gynecol 1976; 126: 137-139.
24. Valenzuela G., Bodkhe R. Effect of pregnancy-induced hypertension upon placental prostaglandin metabolism: decreased prostaglandin F2a catabolism with normal prostaglandin E2 catabolism. AmJ Obstet Gynecol 1980; 136: 255-256.
25. Yamaguchi M., Mori N. 6-Keto prostaglandin F1α, thromboxane B2, and 13, 14-dihydro 15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, delivery, and postpartum period. Am J Obstet Gynecol 1985; 151: 121-127.
26. Hillier K., Smith M. Prostaglandin E and F concentrations in placentae of normal, hypertensive and preeclamptic patients. BrJ Obstet Gynaecol 1981; 88: 274-277.
27. Robinson J. S., Redman C. W. G., Clover L, Mitchell M. D. The concentrations of the prostaglandins E and F, 13, 14-dihydro-15-oxo-prostaglandin F and thromboxane B2. Prostaglandins Med 1979; 3: 224-234.
28. Parsons M. T., Lindsey R., Palumbo T., Lambert B., Spellacy W. N., Wilson L. Prostaglandin production and contractile response of umbilical arteries in preeclamptic pregnancies with and without intrauterine growth retardation. Am J Perinatol 1988; 5: 220-225.
29. Roberts J. M., Redman C. W. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447-1451.
30. Mitchell M. D., Flint A. P., Bibby J. et al. Plasma concentrations of prostaglandins during late human pregnancy: influence of normal and preterm labor. J Clin Endocrinol Metab 1978; 46: 947-951.
31. 2-isoprostane, on endothelin-1 release. J Cardiovasc Pharmacol 1995; 26(Suppl 3): S51-52.
32. 2 production by endothelial cells, smooth muscle cells and fibroblasts cultured from piglet aorta. Biochim Biophys Acta 1982; 712: 103-110.
33. Watson C. A., Camera-Benson L., Palmer-Crocker R., Pober J. S. Variability among human umbilical vein endothelial cultures. Science 1995; 268: 447-448.
34. Alhenc-Gelas F., Tsai S., Callahan K., Campbell W., Johnson A. Stimulation of prostaglandin formation by vasoactive mediators in cultured human endothelial cells. Prostaglandins 1982; 24: 723-740.
35. Geling N., Moldobaeva A., Martynov A. et al. Is prostacyclin a major prostaglandin produced by endothelial cells in culture? Folia Biol 1987; 33: 335-340.
36. Walsh S. W. Physiology of low-dose aspirin therapy for the prevention of preeclampsia. Semin Perinatol 1990; 14: 152-170.